Selective cytoprotection with amifostine in concurrent radiochemotherapy for head and neck cancer
Data up to Jan 2025
Total Citations Per Year
Abstract
References (21)
Reporting results of cancer treatment
1981 • 7,916 citations
Head and Neck Cancer
1993 • 2,263 citations
Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer.
1996 • 455 citations
Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials.
1996 • 385 citations
Prevention of Xerostomia-Related Dental Caries in Irradiated Cancer Patients
1977 • 310 citations
Treatment of Advanced Squamous-Cell Carcinoma of the Head and Neck with Alternating Chemotherapy and Radiotherapy
1992 • 305 citations
Five-Year Update of a Randomized Trial of Alternating Radiotherapy and Chemotherapy Compared With Radiotherapy Alone in Treatment of Unresectable Squamous Cell Carcinoma of the Head and Neck
1996 • 253 citations
Overview of Combined Modality Therapies for Head and Neck Cancer
1993 • 214 citations
Head and neck cancer: chemotherapy concepts.
1988 • 181 citations
Use of radiation with or without WR-2721 in advanced rectal cancer
1992 • 134 citations
Preliminary results of a pilot study using WR-2721 before fractionated irradiation of the head and neck to reduce salivary gland dysfunction
1994 • 111 citations
Biological factors affecting the radioprotective efficiency of S-2-[3-aminopropylamino]ethylphosphorothioic acid (WR-2721): LD 50(7) doses.
1971 • 98 citations
Dental management of patients irradiated for oral cancer
1976 • 76 citations
Biological Factors Affecting the Radioprotective Efficiency of S-2-[3-Aminopropylamino] Ethylphosphorothioic Acid (WR-2721). LD 50(30) Doses
1970 • 65 citations
Radioprotection by WR-2721 against Long-Term Chronic Damage to the Rat Parotid Gland
1978 • 64 citations
Clinical study of the radioprotective effects of amifostine (YM-08310, WR-2721) on chronic radiation injury
1986 • 62 citations
Carboplatin combined with amifostine, a bone marrow protectant, in the treatment of non-small-cell lung cancer: a randomised phase II study
1995 • 55 citations
Short-Term Radioprotective Effects of WR-2721 on the Rat Parotid Glands
1978 • 52 citations
Very accelerated radiation therapy: Preliminary results in locally unresectable head and neck carcinomas
1995 • 36 citations
Split-course accelerated therapy in head and neck cancer: An analysis of toxicity
1995 • 30 citations
Intensive concomitant chemoradiotherapy in locally advanced unresectable squamous cell carcinoma of the head and neck: a phase II study of radiotherapy with cisplatin and 7-week continuous infusional fluorouracil.
1996 • 27 citations